Search research articles
Contact Us
Filters
Showing results (271-280 of 504) with videos related to
Page
of 51
Sort By:
Journal of Neurology
|
December 6, 2018
ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype
Lorenzo Nanetti, Elisa Sarto, Anna Castaldo, et al.
Blood
|
February 7, 2014
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Davide Rossi, Hossein Khiabanian, Valeria Spina, et al.
British Journal of Haematology
|
January 13, 2010
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia
Riccardo Bomben, Michele Dal Bo, Daniela Capello, et al.
Haematologica
|
December 24, 2013
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism
Roberta Rizzo, Valentina Audrito, Paola Vacca, et al.
British Journal of Haematology
|
May 15, 2009
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors
Davide Rossi, Elisa Sozzi, Alessia Puma, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 30, 2024
Three montages for Transcranial electric stimulation in predicting the early post-surgery outcome of the facial nerve functioning
Mikael Gian Andrea Izzo, Davide Rossi Sebastiano, Valentina Catanzaro, et al.
Brain : a Journal of Neurology
|
August 27, 2024
Neurophysiological markers of motor compensatory mechanisms in early Parkinson's disease
Massimiliano Passaretti, Roberto Cilia, Sara Rinaldo, et al.
Hematological Oncology
|
September 6, 2019
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden
Rahel Schwotzer, Markus Gabriel Manz, Stefanie Pederiva, et al.
Haematologica
|
July 22, 2008
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia
Davide Rossi, Antonella Zucchetto, Francesca Maria Rossi, et al.
Oncotarget
|
June 4, 2015
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells
Michele Dal Bo, Tiziana D'Agaro, Stefania Gobessi, et al.
Page
of 51
Search research articles
Search
Showing results (271-280 of 504) with videos related to
Sort By:
Page
of 51
Journal of Neurology
|
December 6, 2018
ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype
Lorenzo Nanetti, Elisa Sarto, Anna Castaldo, et al.
Blood
|
February 7, 2014
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Davide Rossi, Hossein Khiabanian, Valeria Spina, et al.
British Journal of Haematology
|
January 13, 2010
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia
Riccardo Bomben, Michele Dal Bo, Daniela Capello, et al.
Haematologica
|
December 24, 2013
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism
Roberta Rizzo, Valentina Audrito, Paola Vacca, et al.
British Journal of Haematology
|
May 15, 2009
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors
Davide Rossi, Elisa Sozzi, Alessia Puma, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 30, 2024
Three montages for Transcranial electric stimulation in predicting the early post-surgery outcome of the facial nerve functioning
Mikael Gian Andrea Izzo, Davide Rossi Sebastiano, Valentina Catanzaro, et al.
Brain : a Journal of Neurology
|
August 27, 2024
Neurophysiological markers of motor compensatory mechanisms in early Parkinson's disease
Massimiliano Passaretti, Roberto Cilia, Sara Rinaldo, et al.
Hematological Oncology
|
September 6, 2019
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden
Rahel Schwotzer, Markus Gabriel Manz, Stefanie Pederiva, et al.
Haematologica
|
July 22, 2008
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia
Davide Rossi, Antonella Zucchetto, Francesca Maria Rossi, et al.
Oncotarget
|
June 4, 2015
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells
Michele Dal Bo, Tiziana D'Agaro, Stefania Gobessi, et al.
Page
of 51